Weekender 3/27/15

To Our New Jersey Life Sciences Community:

Welcome to another edition of The Weekender.

Congratulations to the Coriell Institute for Medical Research in Camden, for its announcement on March 16 that it has won a $14 million grant from the National Institutes of Health to advance the work of the Institute, which maintains a diverse collection of samples from human genetic diseases.

The NJEDA Board took steps forward on projects under the Grow New Jersey Assistance program, which offers enhanced benefits to companies in targeted industries, including technology, life sciences, energy and health. The EDA approved four businesses in the greater technology industry with tax credits totaling more than $26 million, with the assistance expected to leverage over $37 million in private investment and the creation of 458 new jobs.

Actavis announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental new drug application (sNDA) for SAPHRIS (asenapine) as monotherapy for the acute treatment of manic or mixed episodes associated with Bipolar I disorder in pediatric patients. Congratulations to Actavis and keep the FDA approvals coming.

And finally, BIO has announced that Tom Brokaw, longtime news anchor for NBC Nightly News and cancer survivor, will serve as a keynote speaker at BIO 2015 taking place on June 15-18 at the Philadelphia Convention Center. Brokaw, who has traveled the globe covering events such as elections, summits, political turmoil, war and many other major news stories, will speak on Tuesday, June 16.

Click here for this week’s Weekender